Holen Sie sich die Stockscreener-App
9.65
3.10%
0.30
Schlusskurs vom Vortag:
$9.35
Offen:
$9.45
24-Stunden-Volumen:
669.15K
Relative Volume:
0.27
Marktkapitalisierung:
$1.13B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-10.27
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
+1.15%
1M Leistung:
-9.99%
6M Leistung:
-4.55%
1J Leistung:
-56.56%
1-Tages-Spanne:
$9.38
$9.74
1-Wochen-Bereich:
$9.34
$10.35
52-Wochen-Spanne:
$7.06
$33.48
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.64 | 1.20B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
290.10 | 46.74B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
63.33 | 11.23B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.88 | 11.43B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.74 | 8.38B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.27 | 6.39B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
What drives Evolent Health Inc. stock priceAccelerated investment success - PrintWeekIndia
What makes Evolent Health Inc. stock attractive to long term investorsMarket-crushing profits - jammulinksnews.com
How Evolent Health Inc. stock reacts to Fed policy changesJaw-dropping returns - jammulinksnews.com
What analysts say about Evolent Health Inc. stockHigh-margin investment plays - Autocar Professional
Will Evolent Health Inc. stock split in the near futureDouble-digit growth - jammulinksnews.com
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - 富途牛牛
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
Is Evolent Health Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus
Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest
Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛
Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance
EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛
Evolent Health taps David Lim as chief clinical officer - MSN
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView
BPAS - FinancialContent
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa
Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com
Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan
Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada
The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance
SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan
JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey
Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener
3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance
EVH Stock Up 30% after 5-Day Win Streak - Trefis
Evolent Health (EVH) Announces Positive Developments Amid Market Concerns | EVH Stock News - GuruFocus
Evolent Health (EVH) Rating Reaffirmed by JMP Securities | EVH S - GuruFocus
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.19%
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):